这是一篇来自已证抗体库的有关
人类 PAI-1 (PAI-1) 的综述,是根据27篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合PAI-1 抗体。
PAI-1 同义词: PAI; PAI-1; PAI1; PLANH1
艾博抗(上海)贸易有限公司
domestic rabbit 单克隆(EPR21850-82) | | 艾博抗(上海)贸易有限公司PAI-1抗体(Epitomics, EPR21850-82)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 5a). Oncol Rep (2019) ncbi |
domestic rabbit 多克隆 | | 艾博抗(上海)贸易有限公司PAI-1抗体(Abcam, ab66705)被用于被用于免疫印迹在pigs 样本上 (图 5). J Am Heart Assoc (2016) ncbi |
小鼠 单克隆(1D5) | | 艾博抗(上海)贸易有限公司PAI-1抗体(Abcam, ab125687)被用于被用于免疫印迹在小鼠样本上 (图 1). Iran J Basic Med Sci (2016) ncbi |
小鼠 单克隆(1D5) | | 艾博抗(上海)贸易有限公司PAI-1抗体(Abcam, ab125687)被用于被用于免疫印迹在人类样本上浓度为1:1000. FEBS Lett (2015) ncbi |
小鼠 单克隆(1D5) | | 艾博抗(上海)贸易有限公司PAI-1抗体(Abcam, ab125687)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 4). Mol Med Rep (2015) ncbi |
圣克鲁斯生物技术
小鼠 单克隆(C-9) | | 圣克鲁斯生物技术PAI-1抗体(Santa Cruz, sc-5297)被用于被用于免疫印迹在人类样本上 (图 2a). Sci Rep (2017) ncbi |
小鼠 单克隆(C-9) | | 圣克鲁斯生物技术PAI-1抗体(SantaCruz, sc-5297)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 2c). Oncol Lett (2016) ncbi |
小鼠 单克隆(C-9) | - 免疫细胞化学; 人类; 图 s1a
- 免疫印迹; 人类; 图 3a
| 圣克鲁斯生物技术PAI-1抗体(Santa cruz, sc-5297)被用于被用于免疫细胞化学在人类样本上 (图 s1a) 和 被用于免疫印迹在人类样本上 (图 3a). Cell Cycle (2015) ncbi |
小鼠 单克隆(C-9) | | 圣克鲁斯生物技术PAI-1抗体(Santa cruz, sc-5297)被用于被用于免疫细胞化学在pigs 样本上 (图 1). PLoS ONE (2015) ncbi |
小鼠 单克隆(C-9) | | 圣克鲁斯生物技术PAI-1抗体(Santa Cruz Biotechnology, sc-5297)被用于被用于免疫印迹在人类样本上. J Biol Chem (2014) ncbi |
小鼠 单克隆(C-9) | | 圣克鲁斯生物技术PAI-1抗体(Santa Cruz, sc-5297)被用于被用于免疫细胞化学在人类样本上浓度为1:100. J Biol Chem (2013) ncbi |
赛默飞世尔
小鼠 单克隆(1D5) | | 赛默飞世尔PAI-1抗体(ThermoFisher, MA5-17171)被用于被用于免疫组化-石蜡切片在人类样本上 (图 3b). Cell Metab (2019) ncbi |
小鼠 单克隆(1D5) | | 赛默飞世尔PAI-1抗体(Zymed, 1D5)被用于被用于免疫印迹在人类样本上浓度为1:600. Tumour Biol (2012) ncbi |
安迪生物R&D
小鼠 单克隆(242816) | | 安迪生物R&DPAI-1抗体(R&D Systems, MAB1786)被用于被用于免疫印迹在人类样本上 (图 1d). Cell Rep (2019) ncbi |
亚诺法生技股份有限公司
小鼠 单克隆(1D5) | - 免疫组化-石蜡切片; 人类; 1:200; 图 1a
- 免疫印迹; 人类; 1:1000
| 亚诺法生技股份有限公司PAI-1抗体(Abnova, 1D5)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200 (图 1a) 和 被用于免疫印迹在人类样本上浓度为1:1000. Oncotarget (2015) ncbi |
赛信通(上海)生物试剂有限公司
domestic rabbit 单克隆(D9C4) | | 赛信通(上海)生物试剂有限公司PAI-1抗体(Cell Signaling, 11907)被用于被用于免疫印迹在小鼠样本上 (图 4e, 5f). J Cell Mol Med (2019) ncbi |
domestic rabbit 单克隆(D9C4) | | 赛信通(上海)生物试剂有限公司PAI-1抗体(Cell Signaling Technology, 11907)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 1c). Cell Signal (2017) ncbi |
domestic rabbit 单克隆(D9C4) | | 赛信通(上海)生物试剂有限公司PAI-1抗体(cell signalling, 11907S)被用于被用于免疫印迹在人类样本上 (图 7a). Int J Mol Sci (2016) ncbi |
domestic rabbit 单克隆(D9C4) | - 免疫组化; 人类; 图 5c
- 免疫印迹; 人类; 图 5a
| 赛信通(上海)生物试剂有限公司PAI-1抗体(Cell Signaling, 11907)被用于被用于免疫组化在人类样本上 (图 5c) 和 被用于免疫印迹在人类样本上 (图 5a). Connect Tissue Res (2015) ncbi |
碧迪BD
小鼠 单克隆(41/PAI-1) | | 碧迪BDPAI-1抗体(BD Biosciences, 612024)被用于被用于其他在人类样本上 (图 4c). Cancer Cell (2018) ncbi |
小鼠 单克隆(41/PAI-1) | - reverse phase protein lysate microarray; 人类; 图 st6
| 碧迪BDPAI-1抗体(BD Biosciences, 612024)被用于被用于reverse phase protein lysate microarray在人类样本上 (图 st6). Cancer Cell (2017) ncbi |
小鼠 单克隆(41/PAI-1) | - reverse phase protein lysate microarray; 人类; 图 3a
| 碧迪BDPAI-1抗体(BD Biosciences, 612024)被用于被用于reverse phase protein lysate microarray在人类样本上 (图 3a). Nature (2017) ncbi |
小鼠 单克隆(41/PAI-1) | | 碧迪BDPAI-1抗体(BD Transduction Laboratories, 612024)被用于被用于免疫印迹在人类样本上 (图 7e). Oncogene (2017) ncbi |
小鼠 单克隆(41/PAI-1) | | 碧迪BDPAI-1抗体(BD Transduction Laboratories, 612024)被用于被用于免疫印迹在人类样本上 (图 6b). Breast Cancer Res (2016) ncbi |
小鼠 单克隆(41/PAI-1) | - 免疫组化-石蜡切片; 人类; 1:200; 图 s1
| 碧迪BDPAI-1抗体(BD科学, P612024)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200 (图 s1). BMC Cancer (2016) ncbi |
小鼠 单克隆(41/PAI-1) | | 碧迪BDPAI-1抗体(BD Biosciences, 612025)被用于被用于免疫印迹在人类样本上浓度为1:5000. J Cell Physiol (2015) ncbi |
小鼠 单克隆(41/PAI-1) | | 碧迪BDPAI-1抗体(BD Transduction, 612025)被用于被用于免疫印迹在人类样本上 (图 11). Nucleic Acids Res (2015) ncbi |
Wiley C, Liu S, Limbad C, Zawadzka A, Beck J, Demaria M,
et al. SILAC Analysis Reveals Increased Secretion of Hemostasis-Related Factors by Senescent Cells. Cell Rep. 2019;28:3329-3337.e5
pubmed 出版商
Huang X, Xue H, Ma J, Zhang Y, Zhang J, Liu Y,
et al. Salidroside ameliorates Adriamycin nephropathy in mice by inhibiting β-catenin activity. J Cell Mol Med. 2019;23:4443-4453
pubmed 出版商
Thompson P, Shah A, Ntranos V, Van Gool F, Atkinson M, Bhushan A. Targeted Elimination of Senescent Beta Cells Prevents Type 1 Diabetes. Cell Metab. 2019;29:1045-1060.e10
pubmed 出版商
Peng J, Liang S, Li L. sFRP1 exerts effects on gastric cancer cells through GSK3β/Rac1‑mediated restraint of TGFβ/Smad3 signaling. Oncol Rep. 2019;41:224-234
pubmed 出版商
Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y,
et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10
pubmed 出版商
Yan Y, Zhao W, Huang Y, Tong H, Xia Y, Jiang Q,
et al. Loss of Polycomb Group Protein Pcgf1 Severely Compromises Proper Differentiation of Embryonic Stem Cells. Sci Rep. 2017;7:46276
pubmed 出版商
Cherniack A, Shen H, Walter V, Stewart C, Murray B, Bowlby R,
et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31:411-423
pubmed 出版商
. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017;543:378-384
pubmed 出版商
Hau A, Leivo M, Gilder A, Hu J, Gonias S, Hansel D. mTORC2 activation is regulated by the urokinase receptor (uPAR) in bladder cancer. Cell Signal. 2017;29:96-106
pubmed 出版商
Chan D, Hui W, Wang J, Yung M, Hui L, Qin Y,
et al. DLX1 acts as a crucial target of FOXM1 to promote ovarian cancer aggressiveness by enhancing TGF-β/SMAD4 signaling. Oncogene. 2017;36:1404-1416
pubmed 出版商
LAW M, Ferreira R, Davis B, Higgins P, Kim J, Castellano R,
et al. CUB domain-containing protein 1 and the epidermal growth factor receptor cooperate to induce cell detachment. Breast Cancer Res. 2016;18:80
pubmed 出版商
Ding Y, Zhang H, Lu A, Zhou Z, Zhong M, Shen D,
et al. Effect of urokinase-type plasminogen activator system in gastric cancer with peritoneal metastasis. Oncol Lett. 2016;11:4208-4216
pubmed
Eirin A, Ebrahimi B, Kwon S, Fiala J, Williams B, Woollard J,
et al. Restoration of Mitochondrial Cardiolipin Attenuates Cardiac Damage in Swine Renovascular Hypertension. J Am Heart Assoc. 2016;5:
pubmed 出版商
Liang Q, Wang B, Pang L, Wang Y, Zheng M, Wang Q,
et al. Application of citrate as a tricarboxylic acid (TCA) cycle intermediate, prevents diabetic-induced heart damages in mice. Iran J Basic Med Sci. 2016;19:43-8
pubmed
Wang X, Wang N, Li H, Liu M, Cao F, Yu X,
et al. Up-Regulation of PAI-1 and Down-Regulation of uPA Are Involved in Suppression of Invasiveness and Motility of Hepatocellular Carcinoma Cells by a Natural Compound Berberine. Int J Mol Sci. 2016;17:577
pubmed 出版商
Koussounadis A, Langdon S, Um I, Kay C, Francis K, Harrison D,
et al. Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models. BMC Cancer. 2016;16:205
pubmed 出版商
Pavon M, Arroyo Solera I, Tellez Gabriel M, Leon X, Virós D, Lopez M,
et al. Enhanced cell migration and apoptosis resistance may underlie the association between high SERPINE1 expression and poor outcome in head and neck carcinoma patients. Oncotarget. 2015;6:29016-33
pubmed 出版商
Huna A, Salmina K, Erenpreisa J, Vazquez Martin A, Krigerts J, Inashkina I,
et al. Role of stress-activated OCT4A in the cell fate decisions of embryonal carcinoma cells treated with etoposide. Cell Cycle. 2015;14:2969-84
pubmed 出版商
Carthy J, Sundqvist A, Heldin A, van Dam H, Kletsas D, Heldin C,
et al. Tamoxifen Inhibits TGF-β-Mediated Activation of Myofibroblasts by Blocking Non-Smad Signaling Through ERK1/2. J Cell Physiol. 2015;230:3084-92
pubmed 出版商
Liu X, Chen Z, Xu C, Leng X, Cao H, Ouyang G,
et al. Repression of hypoxia-inducible factor α signaling by Set7-mediated methylation. Nucleic Acids Res. 2015;43:5081-98
pubmed 出版商
Zhang W, Pei Y, Zhong L, Wen B, Cao S, Han J. Pluripotent and Metabolic Features of Two Types of Porcine iPSCs Derived from Defined Mouse and Human ES Cell Culture Conditions. PLoS ONE. 2015;10:e0124562
pubmed 出版商
Li C, Zhu H, Bai W, Su L, Liu J, Cai W,
et al. MiR-10a and miR-181c regulate collagen type I generation in hypertrophic scars by targeting PAI-1 and uPA. FEBS Lett. 2015;589:380-9
pubmed 出版商
Huang W, Li L, Tian X, Yan J, Yang X, Wang X,
et al. Astragalus and Paeoniae Radix Rubra extract (APE) inhibits hepatic stellate cell activation by modulating transforming growth factor-β/Smad pathway. Mol Med Rep. 2015;11:2569-77
pubmed 出版商
Zhang X, Ma Y, You T, Tian X, Zhang H, Zhu Q,
et al. Roles of TGF-β/Smad signaling pathway in pathogenesis and development of gluteal muscle contracture. Connect Tissue Res. 2015;56:9-17
pubmed 出版商
Feng Y, Wu H, Xu Y, Zhang Z, Liu T, Lin X,
et al. Zinc finger protein 451 is a novel Smad corepressor in transforming growth factor-? signaling. J Biol Chem. 2014;289:2072-83
pubmed 出版商
Sharma A, Diecke S, Zhang W, Lan F, He C, Mordwinkin N,
et al. The role of SIRT6 protein in aging and reprogramming of human induced pluripotent stem cells. J Biol Chem. 2013;288:18439-47
pubmed 出版商
Popnikolov N, Dalwadi B, Thomas J, Johannes G, Imagawa W. Association of autotaxin and lysophosphatidic acid receptor 3 with aggressiveness of human breast carcinoma. Tumour Biol. 2012;33:2237-43
pubmed 出版商